Latest News

Editorial: A proposal to correct minority underrepresentation in clinical trials






In an editorial published in CNS Spectrums, Jay Avasarala, MD, Ph.D., takes the research community to task for its lack of minority representation in Phase III clinical trials for drugs to treat Multiple Sclerosis (MS).

Source link




Related posts

Essential Oils Promise Help, But Beware the Risks

Newsemia

Scientists develop new approach to unravel toxic effects of multiple stressors

Newsemia

Celiac disease may now be curable with biodegradable nanoparticles

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy